Immix Biopharma Announces 50% Enrollment Milestone Surpassed in its ongoing relapsed ...

Retrieved on: 2025-09-18 17:48:41

Tags for this article:

Click the tags to see associated articles and topics

Immix Biopharma Announces 50% Enrollment Milestone Surpassed in its ongoing relapsed .... View article details on hiswai:

Excerpt

(“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL Amyloidosis and other ...

Article found on: www.bakersfield.com

View Original Article